Estimating the Adherence Rate of a Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors
Conditions
Breast Cancer
Conditions: official terms
Breast Neoplasms
Conditions: Keywords
Breast cancer, Anti-estrogen therapy
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Intervention
Name: Bubble packaging of subjects prescription
Type: Other
Overall Status
Recruiting
Summary
This study aims to establish the feasibility of using a monthly bubble package to improve compliance rates among women prescribed adjuvant endocrine therapy.
Detailed Description
This study uses Bubble packaging to provide a cost effective way to improve compliance and help direct further interventions to ensure adherence in women on anti-estrogen therapy for breast cancer.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:

- 18 years of age or older

- Estrogen receptor positive (> 1% estrogen expression) by immunohistochemistry

- Invasive breast cancer (stage I, II, III) or DCIS considered for adjuvant endocrine therapy

Exclusion Criteria:

- Patients with metastatic disease (stage IV)

- Patients less than 18 years of age

- Prisoners

- Patients are unable to fill prescriptions at the BCC pharmacy due to insurance limitations or personal preference
Location
James Graham Brown Cancer Center-University of Louisville
Louisville, Kentucky, United States
Status: Recruiting
Contact: Elizabeth C Riley, MD - 502-562-3429
Start Date
July 2012
Completion Date
July 2016
Sponsors
James Graham Brown Cancer Center
Source
James Graham Brown Cancer Center
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page